PSI
LRMR icon

Pinnacle Summer Investments’s Larimar Therapeutics LRMR Stock Holding History

Pinnacle Summer Investments’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-67
Closed -$26K – 911
2015
Q3 		$26K Buy
+67
New +$30.2K ﹤0.01% 587
2015
Q2 		– Sell
-67
Closed -$32K – 853
2015
Q1 		$32K Buy
+67
New +$31.8K ﹤0.01% 580
2014
Q4 		– Sell
-67
Closed -$16K – 1057
2014
Q3 		$16K Buy
+67
New +$15.2K ﹤0.01% 734

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Pinnacle Summer Investments's LRMR Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 67 shares — an estimated $26K sold.

Pinnacle Summer Investments first reported a position in LRMR in Q3 2014 and held it in 3 quarters. The position peaked at $32K in Q1 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Pinnacle Summer Investments reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 67 Larimar Therapeutics shares in Q4 2015, an estimated $26K.
  • Pinnacle Summer Investments first reported a position in Larimar Therapeutics in Q3 2014 and held it in 3 quarters.
  • Pinnacle Summer Investments's Larimar Therapeutics position peaked at $32K in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.